<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01025856</url>
  </required_header>
  <id_info>
    <org_study_id>46/09</org_study_id>
    <nct_id>NCT01025856</nct_id>
  </id_info>
  <brief_title>Combined Nutritional and Exercise Strategies to Reduce Liver Fat Content in Patients With Type 2 Diabetes</brief_title>
  <official_title>Combined Nutritional and Exercise Strategies to Reduce Liver Fat Content in Patients With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study will be to evaluate in patients with type 2 diabetes the effects on
      liver fat of an intervention with a diet relatively rich in CHO/rich in fibre/low GI or a
      diet rich in MUFA, either combined or not with a structured program of physical exercise,
      with emphasis on mechanisms possibly underlining these effects, namely changes in
      postprandial triglyceride-rich lipoproteins, body fat distribution, insulin sensitivity,
      oxidative stress and inflammation, adipose tissue lipolytic activities, aerobic capacity and
      endothelial function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liver fat content</measure>
    <time_frame>0 and 8 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>postprandial lipids metabolism</measure>
    <time_frame>0 and 8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in body fat distribution</measure>
    <time_frame>0 and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxidative stress and inflammation</measure>
    <time_frame>0 and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adipose tissue lipolytic activities</measure>
    <time_frame>0 and 8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Postprandial Lipids Metabolism</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>high fibre/low glycemic index diet - P A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will follow for two months a diet high fibre/low glycemic index without physical activity program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rich in MUFA diet - PA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will follow for two months a rich in MUFA diet without a physical activity program.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high fibre/low glycemic index diet+PA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will follow for two months a high fibre and low glycemic index diet associated with a physical activity program.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rich in MUFA diet+PA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will follow for 2 months a rich in MUFA diet with a physical activity program.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rich in MUFA diet -PA</intervention_name>
    <description>The patients will follow a rich in MUFA diet without a physical activity program.</description>
    <arm_group_label>Rich in MUFA diet - PA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>high fiber/low glycemic index diet + pa</intervention_name>
    <description>patients will follow for two months a high fibre/ low glycemic index diet with a physical activity program.</description>
    <arm_group_label>high fibre/low glycemic index diet+PA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rich in MUFA diet+PA</intervention_name>
    <description>Patients will follow for two months a rich in MUFA diet with a physical activity program.</description>
    <arm_group_label>Rich in MUFA diet+PA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High fibre/low glycemic index diet-PA</intervention_name>
    <description>Patients will follow for two months a high fibre/low glycemic index diet without a physical activity program.</description>
    <arm_group_label>high fibre/low glycemic index diet - P A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and postmenopausal women

          -  Age 35-65 years

          -  BMI 27- 34 kg/m2

          -  HbA1c &lt;8%

          -  Fasting plasma cholesterol &lt;250 mg/dl

          -  Fasting plasma triglycerides &lt;300 mg/dl

        Exclusion Criteria:

          -  Hypolipidemic drugs

          -  Plasma creatinine &gt;1.7 mg/dl transaminases &gt; 2 norma values

          -  Ischemic heart disease or positive treadmill stress test

          -  High intensity regular physical activity

          -  Any disease or chronic or/and acute condition contraindicating physical
             activity(anaemia, and infectious, neoplastic, neurological and osteoarticular
             diseases).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2009</study_first_submitted>
  <study_first_submitted_qc>December 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2009</study_first_posted>
  <last_update_submitted>December 3, 2012</last_update_submitted>
  <last_update_submitted_qc>December 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>rivellese angela</investigator_full_name>
    <investigator_title>PA</investigator_title>
  </responsible_party>
  <keyword>liver fat</keyword>
  <keyword>postprandial lipids metabolism</keyword>
  <keyword>diet</keyword>
  <keyword>exercise</keyword>
  <keyword>type 2 diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

